Immune status in advanced upper gastrointestinal cancers

Area of Science:

• Oncology
• Immunology

Background:

• Advanced upper gastrointestinal cancer presents significant challenges in patient management.
• Immune status is increasingly recognized as a critical factor in cancer progression and treatment outcomes.

Purpose of the Study:

• To assess the immune status of patients with advanced upper gastrointestinal cancer before initiating therapy.
• To investigate potential correlations between immune parameters and clinical factors.

Main Methods:

• Evaluated cell-mediated immunity using absolute lymphocyte count, T-cell count, and delayed cutaneous hypersensitivity reactions.
• Measured immunoglobulin levels (IgA, IgM, IgG).
• Assessed 38 patients with advanced upper gastrointestinal cancer prior to any treatment.

Main Results:

• Severe depression of cell-mediated immunity was observed in patients.
• Elevated levels of Immunoglobulin A (IgA) and Immunoglobulin M (IgM) were noted.
• Reduced levels of Immunoglobulin G (IgG) were found.
• No significant correlation was found between immune status and cancer site, extent, performance status, or chemotherapy response.

Conclusions:

• Patients with advanced upper gastrointestinal cancer exhibit profound immune suppression.
• Immune dysregulation, including altered immunoglobulin profiles, is characteristic of this patient group.
• Immune status does not appear to predict clinical outcomes or treatment efficacy in this cohort.